Changeflow GovPing Healthcare & Life Sciences iEUS-PCL AI System for Multimodal Diagnosis of ...
Routine Notice Added Final

iEUS-PCL AI System for Multimodal Diagnosis of Pancreatic Cystic Lesions

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH ClinicalTrials.gov registered observational study NCT07543263 for an artificial intelligence system named iEUS-PCL designed to detect and diagnose pancreatic cystic lesions during endoscopic ultrasound examinations. The study will develop and validate the multimodal, multi-class diagnostic tool for clinical use.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH registered a new observational clinical trial for an AI diagnostic system called iEUS-PCL intended for multimodal detection and diagnosis of pancreatic cystic lesions during endoscopic ultrasound procedures. The study represents research-stage development and validation of the diagnostic tool.

Healthcare providers and clinical investigators conducting endoscopic ultrasound examinations may encounter this technology upon potential future clinical adoption. Medical device manufacturers developing AI-assisted diagnostic systems in gastroenterology should monitor validation outcomes from this study.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic Cystic Lesions Based on Endoscopic Ultrasonography

Observational NCT07543263 Kind: OBSERVATIONAL Apr 21, 2026

Abstract

The aim of this study is to develop and validate an artificial intelligence system named iEUS-PCL (intelligent endoscopic ultrasound system-pancreatic cystic lesions) for detecting and multimodal, multi-class diagnosing pancreatic cystic lesions (PCL) during endoscopic ultrasound (EUS) examination.

Conditions: Endoscopic Ultrasound (EUS), Pancreatic Cystic Lesion (PCL)

Interventions: iEUS-PCL(intelligent endoscopic ultrasound system- pancreatic cystic lesion)

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 21st, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Docket
NCT07543263

Who this affects

Applies to
Healthcare providers Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration AI diagnostics research Endoscopic ultrasound
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Medical Devices Artificial Intelligence

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!